Page 1

Growing Number of Breast Cancer Cases and Rising Awareness of Breast Cancer among Women Are Offering Lucrative Growth Opportunities for the Breast Biopsy Market

This report segments the breast biopsy market on the basis of product, guidance system, type, and region. Based on type, the breast biopsy market is categorized into the needle and open surgical breast biopsy segments. The needle breast biopsy market is further sub segmented into core-needle biopsy (CNB), fineneedle aspiration biopsy (FNAB) and vacuum-assisted biopsy (VAB) market. Among these, VAB is expected to be the fastest-growing segment during the forecast period. Market growth can be attributed to the growing demand for less-invasive breast biopsies worldwide.

Download the FREE PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=189011805

-:Market Dynamics:Drivers: • Increasing Incidence of Breast Cancer • Increasing Number of Breast Cancer Screening Programs • New Reimbursement Guidelines for Breast Biopsy Procedures in the U.S. • Increasing Demand for Minimally Invasive Surgeries Restraints: • Regulatory Issues • Infection Risks Related to Breast Biopsy Procedures Opportunities: • Growth Opportunities in Emerging Countries Current Trends: • Emergence of Liquid Biopsy


-:Market Segmentation:-

By Guidance System, the market is segmented into mammography, ultrasound, MRI, and others (PET and thermography). The mammography-guided breast biopsy segment accounted for the largest share of the breast biopsy market in 2015 owing to its ease of use and reliability.

You Can Also Request for the Customized Information As Per Your Request On the Basis of Product, the market is classified into biopsy needles, guidance systems, biopsy tables, localization wires, and others (markers, punches, sutures). The guidance systems segment is expected to be the fastest-growing segment during the forecast period owing to the increase in demand for needles. North America and Europe are established markets for breast biopsy. On the Basis of Region, the breast biopsy market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America is expected to account for the largest share of the breast biopsy market, followed by Europe. However, Asia-Pacific is expected to register a higher growth rate during the forecast period. The growth of the breast biopsy market in Asia-Pacific will be centered on China and India. However, developing regions in Asia-Pacific (China and India) are expected to witness a higher growth rate in the forecast period. The growing purchasing power of the middle class and increasing awareness about breast cancer screening in different countries are the major factors fueling the growth of the breast biopsy market in Asia-Pacific. A number of companies are investing in these countries to gain the competitive edge as well as enhance their profitability in the market.


About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

Breast Biopsy Market - New Research Report by MarketsandMarkets  

Key players operating in the market are Becton, Dickinson and Company (U.S.), C.R. Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.),...

Breast Biopsy Market - New Research Report by MarketsandMarkets  

Key players operating in the market are Becton, Dickinson and Company (U.S.), C.R. Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.),...

Advertisement